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Abstract
Background—Atopic dermatitis (AD) is characterized by intense pruritis and is a common 
childhood inflammatory disease. Many factors are known to affect AD development, including the 
pleiotropic cytokine interleukin (IL)-4. Yet, still little is known regarding the direct effects of IL-4 
on keratinocyte function. Objective and Methods: In this report, RNA-seq and functional assays 
were used to define the impact of the allergic environment on primary keratinocyte function and 
wound repair in mice.
Results—Acute or chronic stimulation by IL-4 modified expression of over 1000 genes 
expressed in human keratinocytes that are involved in a broad spectrum of non-overlapping 
functions. Among the IL-4-induced changes, repression of fibronectin critically impaired the 
human keratinocyte wounding response. Moreover, in mouse models of spontaneous and induced 
AD-like lesions there was delayed re-epithelialization. Importantly, topical treatment with 
fibronectin restored the epidermal repair response.
Conclusion—Keratinocyte gene expression is critically shaped by IL-4, altering cell fate 
decisions likely important for the clinical manifestations and pathology of allergic skin disease.
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INTRODUCTION
Atopic dermatitis (AD) is one of the most common inflammatory diseases in children, and is 
characterized by intense pruritis (itch) and abnormal skin (reviewed in 1–3). AD is an early 
indicator of subsequent atopic diseases with roughly 60% of children with AD later 
developing airway hyperresponsiveness 4–6. The pathogenesis of AD involves impaired 
keratinocyte differentiation and diminished skin barrier function, resulting in dry (xerotic) 
skin, increased susceptibility to bacterial and viral infections, and augmented percutaneous 
exposure to environmental allergens 3, 7.
The Th2-type cytokine interleukin (IL)-4 has been shown to impact keratinocyte 
differentiation 7–9. IL-4 is a pleiotropic cytokine secreted by activated T lymphocytes and 
innate immune cells acting through a receptor on hematopoietic cells composed of the 
IL-4Rα and γc receptors (type I IL-4R) 10, 11. Keratinocytes and other non-hematopoietic 
cells do not express γc receptors, but can respond to IL-4 via the type II IL-4R composed of 
IL-4Rα and IL-13Rα112. IL-4 binding to either receptor mediates the phosphorylation and 
dimerization of the Signal Transducer and Activator of Transcription 6 (STAT6), regulating 
transcriptional activation of genes in target cells 9. Keratinocytes exposed to IL-4 exhibit 
reduced expression of Epidermal Differentiation Complex (EDC) genes 13, decreased 
expression of defensins 3, altered expression of keratins 14, and increased production of the 
chemokine CCL26 (eotaxin 3) 15.
IL-4 is an important target in patients, and in clinical trials of subjects with moderate-to-
severe AD, disease scores improved after anti-IL-4Rα human antagonist antibody 
treatment 16. However, there is still little known regarding the consequences of IL-4 
signaling on keratinocyte differentiation and barrier protection. The current study defines the 
global changes induced by IL-4 on gene expression in human keratinocytes via 
bioinformatics analysis of gene expression following high throughput analysis (RNA-seq). 
This analysis identified a wound-healing pathway, including expression of fibronectin by 
keratinocytes, which is repressed by IL-4 treatment and likely contributes to pathology in 
patients with AD. Moreover, modulating this pathway in an in vivo model improved wound 
repair.
MATERIALS AND METHODS
Mice
Female BALB/C and C57BL/6 mice were purchased from Harlan Bioscience (Indianapolis, 
Ind). The generation of Stat6VT transgenic mice was previously described 17. These mice 
express the human STAT6 gene with V547 and T548 mutated to alanine under 
transcriptional control of the CD2 locus control region. IL-4–deficient mice (Il4−/−) were 
purchased from The Jackson Laboratory (Bar Harbor, ME) and mated to Stat6VT transgenic 
mice. Stat6−/− mice were generated and backcrossed for at least 10 generations to BALB/c 
mice as described previously 18. Mouse ears were punched using a 2 mm punch (Kent 
Scientific) to determine the in vivo wound healing response. In some experiments, mice 
were treated for two days with ointment containing BSA (Promega) or fibronectin purified 
from human plasma (Sigma). To determine wounding response in an induced model of AD-
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like disease, WT and Stat6−/− mice were treated with the vitamin D analogue MC903 
(Calcipotriol, Sigma) as previously described 19. MC903 was dissolved in 100% ethanol and 
topically applied on mouse ears (2 nmol in 25 μL per ear) for 5 days. Ethanol alone was used 
as a vehicle control. Ears were punched at day 6 after treatment. Mice were maintained in 
pathogen-free conditions, and all studies were approved by the Animal Care and Use 
Committee of the Indiana University School of Medicine.
Keratinocyte cell culture
Primary human keratinocytes were isolated from excised foreskin tissue as previously 
described 20, and washed with antibiotics. The tissue was minced and the individual cells 
were released from the tissue using trypsin digestion. Keratinocytes and fibroblasts were 
separated by differential resistance to treatment with EDTA. Isolated cells were grown in 
EpiLife Complete media (Life Technologies) with human keratinocyte (HK) growth 
supplement (Life Technologies) and 1000 U penicillin–streptomycin (Roche) and grown as 
unmanipulated cultures or immortalized by the expression of hTERT 21. To stimulate 
keratinocyte differentiation, HK were treated with 2 mM of CaCl2 every other day. Human 
keratinocytes were stimulated with 20 ng/ml or indicated concentration of recombinant 
human IL-4 (R&D Systems) or IL-13 (Peprotech). All HK samples were de-identified, and 
the institutional review board of the Indiana University School of Medicine certified these 
studies as exempt.
Histological and immunofluorescence analysis
Ears tissue was fixed using 10% formalin for 24 hours. Routine histological techniques were 
used to paraffin embed the ears, and 5-μm sections were stained with H&E or Masson’s 
trichrome. Ki-67 expression was analyzed by immunofluorescence using rabbit anti-human 
Ki67 (SP6) antibody and anti-rabbit 488nm. Quantitative digital morphometric analysis of 
the percentage of re-epithelialization was measured using Image J 1.43u. Percentage of re-
epithelialization was calculated by dividing the total pixel length of lesion visualized at days 
3 or 6 after wounding by the pixel length of lesions with incomplete re-epithelialization.
In vitro wound assay and live cell imaging
Normal human keratinocytes were cultured with a 100% confluence in plates covered or not 
with 1 μg/ml of BSA (Promega) or fibronectin from human plasma (Sigma-Aldrich). HK 
were cultured with calcium chloride alone in EpiLife Complete media and stimulated with 
20 ng/ml recombinant human IL-4 as indicated. At days 2 or 5, a cell free area was created 
by scratching the monolayer with a 200 μl pipette tip. Time-lapse photography was 
performed on an automated time-lapse imaging system (Biostation IM-Q, Nikon 
Instruments) every 2 minutes in an environmentally controlled chamber (5% CO2, 37°C) 
(3.2 min) fitted with the 20× NA 0.8 lens and a DS-Qi1 CCD camera. Photoshop (Adobe) 
software platforms were used to export movies.
Organotypic skin equivalent
In vitro skin equivalents were constructed using normal primary fibroblasts and 
keratinocytes isolated from human neonatal foreskins, as previously described 22. The skin 
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equivalents were grown at 35°C in an air incubator for 7–10 days, and fresh media was 
added every two days.
Cell isolation and flow cytometry
Epidermis was separated from dermis following enzymatic treatment with 400 μg/ml of 
liberase (Roche) for 90 minutes at 37°C. Total cells were further isolated from epidermis by 
using gentleMacs dissociator (Miltenyi Biotech) following manufacturer’s instruction. For 
detection of Stat6VT expression, splenocytes, and total epidermis and dermis cell 
suspension were pre-incubated with Fc-block (BD Pharmingen) for 10 min at 4°C bef ore 
incubation with anti-CD45, anti-CD3, anti-CD4, anti-CD8 and anti-CD19 for 30 min at 4°C. 
Human keratinocytes were harvested and incubated with Human TruStain FcX (Biolegend), 
for 10 min at 4°C. The cells were fixe d and permeabilized for intracellular staining with 
phospho-STAT6 Alexa 488 (BD Pharmingen) or anti-Flag APC (DYKDDDDK tag epitope) 
(Bioloegend) antibody before analysis by flow cytometry (Attune® Acoustic Focusing 
Cytometer), as described 23. The results were analyzed using FlowJo (Ashland, OR).
ELISA
Levels of CCL26 were measured in the supernatant of HK using human quantikine ELISA 
kit (R&D Systems). Fibronectin levels were measured in single cell suspension lysates 
isolated from dermis and epidermis as described above. Fibronectin levels were measured 
using mouse ELISA kit (Abcam) following manufacturer’s instruction.
Quantitative RT-PCR
Total RNA was isolated from cells and reverse transcribed according to manufacturer’s 
instructions (Invitrogen Life Technologies, Carlsbad, CA). Quantitative PCR was performed 
with Taqman Fast Universal PCR Master Mix and commercially available primers (Applied 
Biosystems). RNA was normalized to expression levels of β2-microglobulin and relative 
expression was calculated with the 2−ΔΔCt method.
Statistical analysis
Statistical analysis was determined using the unpaired Student’s t-test or ANOVA followed 
by the Tukey’s test for multiple comparisons, and a p value of less than 0.05 was considered 
significant.
Alignment of RNAseq reads to human genome
Total RNA was isolated from immortalized HK cultured under conditions indicated above 
using TRIzol reagent. RNA samples were purified using RNase-Free DNAse kit (Qiagen). 
RNA-Seq libraries were generated by Otogenetics using HiSeq 2000 sequencing instrument 
with 20 million paired-end 100 nucleotide reads per sample, with biological duplicates for 
each condition and results displayed as average samples. The percentage of mapped reads 
(50–56% of sequences) represented a 20X nucleotide coverage of the estimated 
transcriptome. Bioinformatics analysis was performed by the Bioinformatics Core at IUSM. 
Short reads (fastq files) from each sample were independently aligned to human reference 
genome hg19 using tophat (version 2.1.0), with default parameters and known 
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transcriptome. Alignment results were filtered by bamutils v0.5.0 to remove reads with 
multiple mappings. Statistics data of the resulting alignment files were created using 
samtools (version 0.1.18) and bamutils (version 0.5.0). The counts of aligned reads mapping 
to known genes were calculated using bamutils (version 0.5.0). EdgeR (version 2.11) was 
used for differential expression analysis. RNA-Seq data files were submitted to GEO 
(accession number GSE59275). Gene ontology analysis was performed using DAVID 
Bioinformatics resources 24, Venn diagram analyses were generated using Venny, and heat 
maps were created using MultiExperiment Viewer (MEV).
RESULTS
IL-4 responses in human keratinocytes
To begin to define keratinocyte responses to IL-4, we characterized the expression of IL-4 
signaling components. Immortalized human keratinocytes (HK) were cultured for five days 
in calcium chloride and demonstrated increased filaggrin (FLG) expression as an indicator 
of differentiation. Differentiated HK exhibited greater expression of STAT6, IL4R and the 
inhibitory IL13RA2 at day 5, contrasting largely unchanged expression of IL13RA1 during 
the differentiation period (Fig E1, A). Flow cytometric analysis indicated the percentage of 
phospho-(p)STAT6 (Tyr641)-positive keratinocytes and the mean fluorescence intensity 
(MFI) of pSTAT6 peaked 30 minutes after IL-4 stimulation (Fig E1, B and C). Analysis of 
gene expression and chemokine production demonstrated decreased expression of the EDC 
genes filaggrin (FLG), loricrin (LOR), and involucrin (IVL) following long term incubation 
with IL-4, and the induction of CCL26 expression and secretion following short and long 
term incubation with IL-4 (Fig E1, D–F). The parallels between these responses and those 
previously published for isolated keratinocytes and skin tissue validated this approach for 
further studies 8, 9, 25–27.
To broadly determine IL-4-stimulated transcriptional changes in HK, we performed RNA-
Seq analysis. At day 2 of culture, HK were incubated in the presence or absence of IL-4 for 
3 or 24 hours. After 3 hours, IL-4 stimulation resulted in at least a 2-fold change in the 
expression of 47 genes when compared with cells cultured with media alone (Fig 1, A and 
B). After 24 hours, IL-4 stimulation resulted in a differential expression of 1164 genes (Fig 
1, A and B). The genes most differentially regulated at both time points are indicated by the 
heatmap in Fig 1, C. Among the transcripts increased at 24 hours that were classified by 
DAVID analysis, 39 were associated with regulation of cell death, 33 were involved with 
immune response and cytokine-receptor interaction, and 31 were involved with regulation of 
cell cycle (Fig 1, D). Transcripts for proteins involved with cell adhesion, response to 
organic substances, and intracellular transport and secretion were the largest functional 
categories of genes whose expression was decreased by IL-4.
To extend these finding, three-dimensional cultures (human skin equivalents) were treated 
with IL-4 for 24 hours before testing the expression of 7 IL-4-induced genes. Treatment with 
IL-4 resulted in a significant increase in CCL26, CA2, CISH, and SERPINB4 (Fig E2, A). 
Additionally, IL-4 effects on HK monolayer gene expression increased in dose dependent 
manner (Fig E2, B). Like IL-4, IL-13 alters gene expression in keratinocytes 12,14. To 
determine whether IL-4 and IL-13 have similar function in regulating HK gene expression, 
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HK were differentiated and stimulated with IL-4 or IL-13 for 5 days before analyzing the 
expression of genes. IL-13 decreased FLG, IVL, LOR and FN1 similarly to IL-4 (Fig E2, 
C). IL-13 also resulted in a comparable increase in SERPINB3 and SERPINB4, but only a 
partial increase in CCL26 and CISH expression when compared to IL-4. Collectively, these 
data showed that acute stimulation of keratinocytes with IL-4 alters the expression of genes 
encoding proteins with diverse functions that could ultimately influence local inflammatory 
responses, alter cell proliferation and survival, and favor loss of cell adhesion.
RNA-Seq analysis of keratinocytes chronically stimulated with IL-4
As shown in Fig. E1, D, exposure of keratinocytes to calcium chloride for 5 days resulted in 
altered expression of differentiation related genes. Thus, to determine whether IL-4 modifies 
genes expressed by keratinocytes in later phases of differentiation, we performed RNA-seq 
analysis of HK differentiated for five days and incubated with or without IL-4, before 
comparing the results to HK cultured for two days. HK differentiated for 5 days exhibited 
differential expression of 1724 genes when compared with HK at day 2, with IL-4 altering 
expression of 303 genes (Fig 2, A and B). The expression pattern for a subset of genes in 
IL-4-stimulated HK at day 5 of culture was similar to the expression pattern in control HK at 
day 2 (Fig 2, C). IL-4 also increased the expression of a set of genes compared to 
unstimulated HK at either time point (Fig 2, C). A Venn diagram shows the 1166 genes 
increased and 558 genes decreased during HK differentiation (Fig 2, B). IL-4 attenuated 
differentiation-induced changes in gene expression of 71 genes (45 were decreased and 26 
were increased) (Fig 2, B). Moreover, IL-4 further augmented the expression of 4 genes and 
decreased the expression of 1 gene in calcium-differentiated HK (Fig 2, B). We also 
observed that IL-4 increased 200 genes and decreased 27 genes in HK that were not 
differentially expressed during differentiation (Fig 2, B). A gene ontology analysis of IL-4-
regulated genes showed that chronic exposure to IL-4 increased transcription of 25 genes 
involved with cell adhesion, and 17 genes related with cell projection. IL-4 decreased 
transcription of 9 genes involved with wound healing and 8 genes involved in host defense 
(Fig 2, D).
IL-4 impairs keratinocyte wound healing response
As noted above, a subset of genes regulated by IL-4 impacts the wound repair process. This 
observation is consistent with diminished wound repair in children that show signs of 
increased atopy 28, and with the diminished recovery of transepidermal water loss following 
injury in Stat6VT transgenic mice, a model of allergic skin inflammation 9, 27. To investigate 
whether IL-4-induced changes in the wound healing subset of genes alter functional activity 
of HK, we assayed for wound healing capacity in culture. HK were differentiated for 2 or 5 
days and cultured in the presence or absence of IL-4. Scratches were made in the confluent 
monolayer to simulate wounding, and wound closure was monitored over 48 hours. Time-
lapse analysis showed that differentiated keratinocytes migrate towards the wound area 
within 24 hours and partially close the wound space (Fig E3, A). Proliferative cells were 
observed in the area adjacent to the wound edge (Online movies) while cells at the edge 
guided the movement of neighboring cells. In contrast, IL-4-stimulated keratinocytes failed 
to migrate toward the wound edge and exhibited significantly less wound closure in both 
cultures when compared with the control cells (Fig E3, B). Since IL-4 decreases the 
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potential wound healing response of HK at days 2 and 5 differentiation, we used the RNA-
seq analysis to better define a target gene involved in the reduced wounding at both time 
points. Thus, as we observed, at days 2 and 5 of differentiation IL-4-treated HK exhibited 
reduced FN1 expression (Fig E3, C). Keratinocytes cultured with increasing concentrations 
of IL-4 exhibited reduced levels of FN1 mRNA (Fig 3, A). These cells also exhibited 
reduced fibronectin production (Fig 3, B), and decreased FN1 mRNA expression 3 hours 
after scratch of monolayers in the in vitro wound-healing assay (Fig 3, C). To further assess 
whether fibronectin potentiates wound-healing response in IL-4-treated HK, cells were 
differentiated for 5 days in control plates, BSA-coated plates or fibronectin-coated plates and 
cultured in the presence or absence of IL-4. A quantitative analysis showed that IL-4-treated 
HK cultured on a fibronectin substratum exhibited a significant increase in wound closure 
when compared with HK cultured on control or BSA substratum with IL-4 (Fig 3, D and E). 
Collectively, IL-4 potently inhibits the wound-healing capacity of keratinocytes by inhibiting 
fibronectin production.
Impaired skin wound healing response in models of AD-like disease
Since IL-4 decreased keratinocytes wound closure, mice with spontaneous development of 
AD-like lesions (Stat6VT mice) were used to test the influence of the allergic environment 
on in vivo wound healing. Stat6VT mice overexpress an active form of STAT6 in T cells, 
resulting in predominant Th2-type cytokine production and allergic skin inflammation 17, 27. 
Importantly for these studies, Stat6VT expression was observed in CD45+ cells, but not in 
CD45− cells isolated from dermis and epidermis in transgenic mice, and was predominantly 
observed in CD4+ cells (Fig E4). To investigate the re-epithelialization process in an atopic 
environment, we used an ear punch (2 mm in diameter) to wound ears of 4–6 month old WT, 
Stat6VT, and Il4−/− Stat6VT mice (Fig 4, A). It is important to note that there is no 
difference in the appearance of skin before wounding (Fig 4, B). Through histological 
analysis over 6 days after wounding, we monitored lesion re-epithelialization and wound 
closure. At day 1 following wounding, wounds in all groups of mice exhibited a neutrophilic 
infiltrate (Fig 4, C). At this time point, only WT and Il4−/− Stat6VT showed a denser 
epidermis at the border of the wounds (Fig 4, C). Further analysis in the control group (i.e. at 
day 3 and 6) showed reduction in cellular infiltration, and continuous re-epithelialization. In 
contrast, Stat6VT mice exhibited pronounced tissue inflammation associated with edema, 
and delayed wound closure (Fig 4, C).
To determine whether differences in wound healing in WT, Stat6VT, and Il4−/− Stat6VT 
mice correlate with poor epithelial proliferation, ears sections were stained by 
immunofluorescence with the KI-67 nuclear protein expressed during cell proliferation (Fig 
4, D). At all time points, all mice exhibited KI-67 positive cells in dermis and epidermis. 
However, WT mice and Il4−/− Stat6VT showed more intense stain in the epidermis mainly at 
days 1 and 3 after punch when compared to Stat6VT mice. At day 3, proliferative cells 
circumscribed most of the lesion in WT mice, and at day 6 the intensity of KI-67 stain was 
attenuated. Stat6VT mice exhibited delayed epidermal proliferation and inefficient lesion 
closure.
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To verify whether deficient re-epithelialization also occurs in an induced model of AD-like 
disease, and to determine if IL-4 signaling normally regulates this process, WT and Stat6−/− 
mice were treated with the vitamin D analog (MC903) for 5 days prior to wounding. Wound 
healing was monitored at days 3 and 6 after punch and wound closure was measured by 
morphometric analysis. We observed a significant decrease in wound closure at day 3 in WT 
mice, compared to control mice treated with ethanol alone (Fig E5, A and B). Moreover, 
Stat6−/− mice exhibited earlier re-epithelialization when compared to WT mice treated with 
MC903 (Fig E5, A and B). Thus, in models of induced and spontaneous AD, an atopic 
environment worsens re-epithelialization and wound healing responses in the skin.
Topical fibronectin enhances skin wound healing in Stat6VT mice
Th2-type cytokines can promote pro-fibrotic pathways involved in tissue regeneration via 
induction of alternatively activated (M2) macrophages differentiation 29. However, in our 
model, the IL-4/STAT6 axis decreases skin wound healing. To explore this apparent 
contradiction, we tested the expression of cytokines and M2 markers in WT and Stat6VT 
intact ears (0 hour), and 3 and 24 hours after punch. We observe that Arg1 (arginase), Retnla 
(Fizz1), and Chi3l3 (Ym1) mRNA levels were significantly increased at 0h in Stat6VT mice 
(Fig 5, A) when compared to WT mice. Il4, Arg1 and Retnla expression are increased at 3 
and 24 hours after wounding in WT, but do not reach the levels observed in transgenic mice. 
Additionally we observed that Fn1 mRNA was similar at 0h in WT and Stat6VT mice (Fig 
5, A). However, at 3 hours after wounding, tissue from WT mice showed an increase in 
fibronectin expression, and tissue from Stat6VT mice exhibited a significant reduction in 
Fn1 mRNA when compared to intact ears or to WT mice (Fig 5, A). Likewise, Il4 mRNA 
levels are increased and Fn1 mRNA levels are decreased in non-lesion and lesion from 
Stat6VT mice compared to intact skin from WT mice (Fig 5, B). Additionally, fibronectin 
levels measured by ELISA were significantly lower in epidermis of Stat6VT mice at 24 
hours after wounding when compared with samples from WT mice (Fig 5, C).
As fibronectin production was reduced in HK culture following IL-4 stimulation, and since 
this protein increased IL-4-stimulated HK scratch closure, we next determined whether 
topical application of fibronectin accelerates wound healing in allergic mice. To test the 
involvement of fibronectin in the Stat6VT mouse wound healing response, WT and Stat6VT 
mice were treated with ointment containing 10 μg of BSA or fibronectin right after (day 1) 
and 24 hours (day 2) after wounding. Histological analyses were performed at day 3, a 
period when partial re-epithelialization was observed (Fig 4, C). Macroscopic analysis 
revealed fibronectin treatment improved tissue recovery and erythema surrounding the lesion 
(Fig 5, D). In histological analysis (Fig 5, E) and morphometric analysis (Fig 5, F), topical 
fibronectin treatment significantly improved wound closure in Stat6VT mice, compared to 
control protein treated mice, but had modest effects on wild type mice. We also observed 
that fibronectin significantly increased wound closure in Stat6VT mice at day 5 after 
wounding when compared with Stat6VT mice receiving ointment alone as control (Fig 5, 
G). Thus, although IL-4 affects the expression of various genes directly involved in 
responses to wounding, the IL-4-dependent repression in fibronectin expression appears to 
be a major target in contributing to the reduction of wound healing potential of keratinocytes 
in an allergic environment.
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DISCUSSION
IL-4 promotes the development of atopic diseases through affects on multiple cell types. 
Despite its critical role in AD, how IL-4 alters gene expression in keratinocytes has not been 
completely defined. In this report we use high throughput transcriptome analysis to identify 
IL-4-induced changes in keratinocyte gene expression at early and late stages of 
differentiation. Acute and chronic IL-4 stimulation resulted in extensive changes in the gene 
expression profile that spanned a variety of functional modules, including wound healing, a 
biological response impaired by IL-4. Moreover, central for IL-4-mediated effects in delayed 
wound healing was reduction in fibronectin production.
IL-4 alters a number of biological processes in keratinocytes, and cells in different stages of 
differentiation showed changes in distinct functions. Acute IL-4 stimulation (3 hours and 24 
hours) resulted in alterations in genes involved in cell growth and survival, and diminished 
expression of genes involved in cell adhesion, which together might contribute to epidermal 
hyperplasia, spongiosis, and diminished barrier function, all characteristics of AD patient 
lesional skin 30–32. At day 5 of differentiation, IL-4 increased genes involved in cell 
projection and adhesion; and decreased genes participating in response to wounding and 
defense. In fact, a subset of genes in IL-4-stimulated differentiated HK (day 5) was similar 
in expression to less differentiated HK (day 2). These changes might favor a less organized 
epithelial structure, and contribute to an increased susceptibility to infections, also 
characteristics of AD lesions 33, 34. Although most of the experiments utilized immortalized 
human keratinocytes, and these might not entirely replicate intact skin, similar responses 
were observed with primary keratinocytes and skin equivalents made with primary cells. 
Moreover, several genes induced by IL-4, including CCL26, S100A7, S100A12, IL12RB, 
LCE3E, SERPINB3, SERPINB4, ADAMTS4, were also elevated in skin from patients with 
AD 35, 36, indicating a possible role for IL-4 in mediating many abnormalities in AD patient 
skin barrier.
Intense pruritis is a characteristic and often debilitating feature of AD, causing patients to 
scratch and consequently wound their skin (reviewed in 37). Lesions are frequently 
associated with areas that patients readily reach to scratch 38, 39. As our data indicates, IL-4 
exposure might also contribute to AD pathogenesis by impairing appropriate wound repair. 
Using scratching of keratinocyte monolayers and time-lapse video microscopy, we 
demonstrate a significant decrease in recovery of the monolayer following IL-4 exposure. 
This observation could be linked to reports that children with AD demonstrating greater 
atopic responses had increased healing time of lesions 28. In contrast to the wound healing 
process observed here, recovery of barrier function following tape stripping of non-lesional 
skin in AD patients and healthy controls was similar 40. Koning and colleagues reported no 
differences in gene expression between tape-stripped non-lesional skin of AD patients versus 
skin from healthy controls 41, suggesting that decreased wound healing would most likely be 
observed in skin with a wound more severe than superficial tape stripping, or in skin with an 
active inflammatory response.
IL-4 has previously been shown to be a pro-healing cytokine in wound repair 29, 42–45. Our 
studies differ from these studies in several ways. First, we are focusing on re-
Serezani et al. Page 9
J Allergy Clin Immunol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
epithelialization of the skin, rather than fibrosis and repair below keratinocyte layers. We 
observed diminished re-epithelialization in two models of AD-like skin inflammation, and 
impaired healing was not observed when mice had defects in IL-4 signaling, suggesting this 
is a consistent effect of a pro-atopic environment. Importantly, we did not observe any 
defects in collagen deposition in the dermis during healing (data not shown). Second, the 
IL-4 induced during wound repair in wild type mice is much less than observed in atopic 
models. We directly demonstrated that M2 gene expression, a common target of IL-4 in 
wound healing studies, is already higher in skin from ‘atopic’ mice. Moreover, the induction 
of these genes is increased in the skin of ‘atopic’ mice. Together, these observations support 
a model wherein a low level of IL-4, functioning particularly in the dermis, is important for 
a healing response. However, in an atopic environment, IL-4 is at sufficiently high 
concentrations to alter keratinocyte function and dermal M2 gene expression. In this respect, 
it is not clear that the effects of IL-4 on fibronectin production are strictly on keratinocytes. 
In our analyses, we did observe diminished fibronectin protein in both dermis and epidermis, 
suggesting that other cells might be affected by IL-4 in a similar fashion. Still, the in vivo 
results are consistent with the in vitro keratinocyte cultures demonstrating an important 
contribution of keratinocyte-produced fibronectin in re-epithelialization.
It is difficult to separate the direct effects of IL-4 in these models versus the effect of IL-4-
dependent inflammation in the AD models. We observed that there was greater loss of 
fibronectin expression in lesional skin than in non-lesional skin of the Stat6VT mice. 
However, there was also greater Il4 expression in lesional skin, demonstrating how these 
factors are linked. Although the in vivo phenotype is consistent with the in vitro 
observations of keratinocyte function, we cannot exclude a contribution of additional cell 
types in vivo that are responding to IL-4 and mediating some of the delayed healing through 
secondary effects.
While IL-4 modifies many genes involved in the wound response 42, decreased fibronectin 
expression directly contributed to the in vitro impairment of HK monolayer wound closure. 
Fibronectin is a multidomain protein component of the extracellular matrix, expressed in 
high levels at wound sites 46, 47. It is associated with wound repair by, among other 
mechanisms during injury, enhancing growth factor binding stability and cell survival 48, 49. 
Although topical application of fibronectin in lesions of Stat6VT mice only partially restored 
re-epithelialization, this protein significantly improved the appearance of lesions, including 
decreasing erythema in the tissue. Many functions regulated by fibronectin including 
adhesion, migration and differentiation 50 were also functions affected in HK following IL-4 
stimulation. Thus, whether fibronectin might be used to treat AD lesions or other biological 
defects induced by IL-4 in keratinocytes are interesting questions remaining to be 
investigated.
Together our findings describe a comprehensive role for IL-4 in preventing keratinocyte 
maturation by influencing the expression of key genes affecting skin barrier function. 
Induction of a subset of genes by IL-4 was confirmed in skin equivalents, and a deficient 
response of keratinocytes from allergic mice to wounding was also observed in vivo, further 
supporting a physiological role for these studies. The more detailed understanding of IL-4-
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regulated genetic programs in keratinocytes described in this report should lead to additional 
insights into the development of allergic skin disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key Message
IL-4, a critical effector cytokine in atopic dermatitis, repressed expression 
of genes induced during keratinocyte differentiation.
Keratinocytes exposed to IL-4 have changes in the expression of over 1000 
genes.
IL-4 impaired the wound healing response of keratinocytes by decreasing 
fibronectin production.
Topical fibronectin increases wound healing in mice with spontaneous AD-
like disease.
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Figure 1. IL-4 modifies human keratinocyte (HK) gene expression
HK were differentiated for 2 days with calcium chloride and stimulated with IL-4 for 3 and 
24 hours before RNA-seq analysis. (A) Graphical representation of genes that were enriched 
at least 2-fold in IL-4-stimulated keratinocytes (red dots). (B) Venn diagram representing the 
number of genes altered by IL-4 after 3 and 24 hours. (C) Heatmap comparison of gene 
enrichment in IL-4-stimulated HK using MeV software. (D) Gene ontology analysis using 
the differential expression of genes at 24 hours after IL-4. Clustering was performed using 
David bioinformatics database analysis. Data represent average of two biological replicates 
for each condition. *p<0.05 and FDR<0.1
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Figure 2. Chronic IL-4 stimulation alters gene expression associated with normal differentiation 
in keratinocytes
Human keratinocytes (HK) were differentiated for 5 days with calcium chloride in the 
presence or absence of IL-4 before RNA-seq analysis. (A) Graphical representation of genes 
enriched at least 2-fold in control HK at day 5 of differentiation and in IL-4-stimulated 
keratinocytes (red dots). (B) Venn diagram representing the number of genes differentially 
expressed at day 5 by keratinocytes cultured with calcium chloride alone (compared with 
day 2) and after IL-4. (C) Heatmap comparison using MeV software of gene enrichment in 
keratinocytes cultured for 2 or 5 days with calcium chloride alone or for 5 days with IL-4. 
(D) Gene ontology analysis performed using genes differentially expressed after 5 days of 
stimulation with IL-4. Clustering was performed using David bioinformatics database 
analysis. Data represent average of two biological replicates for each condition. p<0.05 and 
FDR<0.1
Serezani et al. Page 17
J Allergy Clin Immunol. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. IL-4-stimulated keratinocytes show delayed wound healing
(A) Human keratinocytes (HK) were differentiated for 5 days with calcium chloride in the 
presence or absence of IL-4 before analysis of FN1 expression by qRT-PCR. (B) Cell lysates 
were collected and the expression of fibronectin and β-actin was determined by western blot 
(C) Gene expression was analyzed 3h after scratching using qRT–PCR. (D) Percentage of 
scratch closed after 24h of culture, and (E) microscopy of human keratinocytes 
differentiated with calcium chloride alone or calcium chloride plus IL-4 for 5 days in control 
or plates covered with a substratum of BSA or fibronectin. Dashed red lines represent 
original wounds. Pictures are representative of 4 fields analyzed over at least three 
independent experiments. Data represents the mean of three independent experiments. 
*p<0.05.
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Figure 4. Stat6VT mice exhibit delayed wounding healing
Lesions were monitored by H&E in ears of WT, Stat6VT and Il4−/− Stat6VT mice at days 1, 
3 and 6 after wounding (dermis (der) and epidermis (epi) separated by dashed lines). (A) 
Representation of ear punch. (B) Visualization of histological sections from distal areas from 
lesion and (C) lesion re-epithelialization and wounding closure. (D) Immunofluorescence 
for the proliferation marker Ki67 (green fluorescence) in the ears of WT, STAT6VT and 
Il4−/− Stat6VT mice in indicated days after punch. Nuclei are stained with DAPI in blue. 
Scale bar: 200μm. Pictures are representative of 3–4 mice from 2 independent experiments.
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Figure 5. Topical fibronectin improves wound healing potential in Stat6VT mice
(A) Gene expression was determined by qRT-PCR in ears of WT and Stat6VT mice before 
(0 hour) and 3 and 24 hours after wounding, or (B) in non-lesion in WT and Stat6VT mice, 
and mice with spontaneous lesions. (C) Fibronectin levels were measured by ELISA in 
dermis and epidermis in WT and Stat6VT mice 24 hours wounding punch. Fold change was 
determined over intact skin (0 hours). (D) Ear representation and (E) lesions monitored by 
H&E in ears of WT and Stat6VT at day 3 after wounding (open wound size (w) measured 
by morphometry are indicated by dotted black lines). (F) Morphometric analysis of 
percentage of wound closure at day 3 after punch in WT and Stat6VT mice treated with 
ointment containing BSA or fibronectin, or (G) at day 5 after wounding in Stat6VT mice 
treated with ointment alone or ointment containing fibronectin. Data represents the mean of 
two independent experiments *p<0.05. Scale bar: 200μm. Pictures are representative of three 
mice from two independent experiments.
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